Regenxbio (NASDAQ:RGNX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.

Open	$7.36
Close	$7.62
Volume / Avg.	10.68M / 867.16K
Day Range	$7.21 - $7.75
52 Wk Range	7.38 - 28.80
Market Cap	$381.99M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	13.88%
Days to Cover	5.01

Recent News

What's Going On With REGENXBIO Shares Monday?

REGENXBIO stock is trading higher on Monday after the company reached a critical point in its trial for Duchenne gene therapy.

Dylan Berman

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Wall Street Analysts Think Regenxbio Could Surge 234.37%: Read This Before Placing a Bet

Shares of Regenxbio (NASDAQ: RGNX) have gained 17.7% over the past four weeks to close the last trading session at $12.51, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.36
Close	$7.62
Volume / Avg.	10.68M / 867.16K
Day Range	$7.21 - $7.75
52 Wk Range	7.38 - 28.80
Market Cap	$381.99M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	13.88%
Days to Cover	5.01

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Regenxbio (RGNX) stock?

You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.

View our list of the best stock brokerages

Who are Regenxbio (RGNX) competitors?

Other companies in Regenxbio’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Sage Therapeutics (NASDAQ:SAGE).

What is the forecast, or price target, for Regenxbio (RGNX) stock?

Regenxbio has a consensus price target of $37.33.

What is the current price for Regenxbio (RGNX)?

The stock price for Regenxbio (NASDAQ: RGNX) is $7.71 last updated December 20, 2024 at 7:01 PM EST.

Does Regenxbio (RGNX) pay a dividend?

There are no upcoming dividends for Regenxbio.

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

Regenxbio’s Q4 earnings are confirmed for Tuesday, February 25, 2025.

Is Regenxbio (RGNX) going to split?

There is no upcoming split for Regenxbio.

What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Regenxbio

Regenxbio (RGNX) Forecast